--- title: "Semaglutide in India" description: "Everything about semaglutide drug class in India: forms, cost, safety, CDSCO approval, and how it differs from tirzepatide." canonical: "https://www.kesho.health/keywords/semaglutide-india" markdown_url: "https://www.kesho.health/md/keywords/semaglutide-india" language: "en-IN" primary_keyword: "semaglutide India" --- # Semaglutide in India — drug-class guide > **Short answer:** Semaglutide is a GLP-1 receptor agonist approved in India for type 2 diabetes and chronic weight management. Available as weekly injection and daily oral tablet. Generic versions have reduced costs since 2024. Requires prescription and CDSCO-approved sourcing. **Canonical HTML:** https://www.kesho.health/keywords/semaglutide-india **Markdown:** https://www.kesho.health/md/keywords/semaglutide-india ## Plan your spend **Check chemist quote** — Compare a pharmacy quote against typical CDSCO-approved GLP-1 ranges — spot grey-market pricing before you pay. [Check chemist quote](https://www.kesho.health/chemist-quote-check) **GLP-1 readiness check** — Educational self-assessment on eligibility signals, safety flags, and what to discuss with your doctor — not a prescription. [GLP-1 readiness check](https://www.kesho.health/glp-1-assessment) ## What is semaglutide? Semaglutide is a long-acting GLP-1 receptor agonist that improves HbA1c, reduces appetite, and supports weight loss. It is a drug class molecule — not a single brand. CDSCO has approved it for specified indications under physician supervision. ## Injectable vs oral semaglutide Weekly subcutaneous injection is the most established form. Oral semaglutide (daily tablet on empty stomach) suits injection-averse patients but has stricter timing rules. Efficacy is broadly similar at equivalent doses in trials. ## Generic semaglutide in India Following patent developments, CDSCO-approved generic semaglutide from licensed Indian manufacturers offers lower monthly costs. Verify bioequivalence, batch numbers, and cold-chain handling — not social-media sellers. ## Who prescribes semaglutide in Indian practice Endocrinologists, internal medicine specialists, and cardiologists with metabolic expertise commonly initiate GLP-1 therapy when RSSDI and ICMR criteria are met. Diabetologists and some bariatric physicians also prescribe within their scope. Your primary care physician may refer you when BMI, HbA1c, or comorbidity patterns warrant specialist input. ## CDSCO approval and Schedule H rules Semaglutide is a Schedule H prescription medicine in India. Purchase only from licensed pharmacies with valid prescriptions. Package inserts list approved indications—using semaglutide outside physician-directed indications carries medical and legal risk. Cross-check product names against CDSCO approved drug lists quarterly as generics enter the market. ## Semaglutide vs other GLP-1 drug classes Semaglutide is one molecule within the broader GLP-1 receptor agonist class. Tirzepatide adds GIP activity; liraglutide requires daily injection. Your doctor selects based on glycaemic targets, weight goals, side-effect tolerance, kidney function, and monthly budget—not social media brand rankings. Kesho compares drug classes without promoting any manufacturer. ## Storage and travel for Indian patients Unopened semaglutide pens require refrigeration at 2–8°C. After first use, most products tolerate room temperature up to 30°C for several weeks—critical during Indian summers. Use insulated travel cases on trains and flights. Never use pens that were warm for extended periods or past in-use expiry dates printed on the label. ## HbA1c and weight monitoring on semaglutide RSSDI follow-up typically includes HbA1c every three months during titration, then every six months at maintenance if targets are met. Weight and waist circumference track monthly at home. Indian patients with fatty liver or prediabetes may need additional liver enzyme panels. Bring logs to every consultation—structured data improves dose decisions. ## Ayurveda and supplement interactions Inform your physician about ayurvedic diabetes or weight products—some contain hidden metformin-like compounds or stimulants that interact with appetite suppression. Protein supplements are generally safe but do not replace meals during severe nausea. Turmeric and fenugreek in normal dietary amounts rarely conflict; concentrated extracts need medical review. ## Complete semaglutide guide on Kesho Our cornerstone semaglutide guide covers CDSCO status, oral versus injectable forms, generic pricing, safety, and doctor preparation in 3,800+ words with references. This landing page summarises search intent; the full guide provides evidence rails and FAQ schema for deeper reading. Markdown alternate available for research agents. ## Questions to ask your prescriber Ask about titration schedule, expected HbA1c target, monthly cost range at maintenance, storage during summer travel, symptoms requiring urgent contact, and generic alternatives if budget tightens. Frame questions around the semaglutide drug class—not a brand seen on social media. Request follow-up appointment before leaving if therapy starts. ## Semaglutide in elderly Indian patients Frail elderly patients require cautious assessment—excessive weight loss may worsen sarcopenia and fall risk. Kidney function declines with age; dosing adjusts accordingly. Polypharmacy is common; review all medicines including ayurvedic preparations before starting. Family caregivers should attend consultations to understand injection technique and warning signs. ## Festival and wedding season eating Indian social calendars centre on shared meals during Diwali, Eid, and weddings. Semaglutide reduces appetite but does not eliminate social pressure to eat. Plan smaller portions, prioritise protein, and avoid greasy mithai during titration when nausea peaks. Discuss temporary dose timing adjustments with your physician for multi-day events—not unsupervised skipping. ## When semaglutide is not the first choice Severe gastroparesis, active pregnancy planning, MTC/MEN2 history, or type 1 diabetes exclude semaglutide use. Some patients prefer daily liraglutide for finer dose control despite injection frequency. Cost may favour generic semaglutide over oral forms at equivalent exposure—pharmacy quotes determine practical choice. ## Renal dosing considerations Semaglutide dosing may adjust in advanced kidney disease—bring creatinine and eGFR results to consultations. RSSDI guidance emphasises individualised targets in diabetic kidney disease. Never alter dose based on online charts without physician confirmation. Kidney monitoring continues quarterly during first year of therapy for high-risk patients. Discuss dialysis timing if eGFR is declining. ## Quick questions ### Is Semaglutide in India information on Kesho medical advice? No. Kesho provides drug-class education only. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised treatment decisions. ### Where is the full guide? See our complete medically reviewed guide linked on this page for in-depth coverage with references and India-specific context. ### What is the short answer on semaglutide in india? Semaglutide is a GLP-1 receptor agonist approved in India for type 2 diabetes and chronic weight management. Available as weekly injection and daily oral tablet. Generic versions have reduced costs since 2024. Requires prescription and CDSCO-approved sourcing. ## Complete guide [semaglutide-india-complete-guide](https://www.kesho.health/blog/semaglutide-india-complete-guide) · [MD](https://www.kesho.health/md/blog/semaglutide-india-complete-guide) ## Related guides - [Is Semaglutide Safe in India? What Patients Should Know](https://www.kesho.health/blog/is-semaglutide-safe-india) - [Oral Semaglutide in India: What Patients Should Know](https://www.kesho.health/blog/oral-semaglutide-india-what-to-know) - [Oral vs Injectable Semaglutide in India: Which Form Fits You?](https://www.kesho.health/blog/rybelsus-vs-injection-india) --- *Drug-class education only — not medical advice. [Kesho](https://www.kesho.health)*